For people with drug-resistant epilepsy, finding a new way to stop seizures is urgent. A small early-phase study looked at a closed-loop, subgaleal intersectional short-pulse stimulation system. This device delivers tiny electrical pulses through electrodes placed just under the scalp. The goal was to see if it was safe and could work quickly.
During the first three days of inpatient treatment, the results were striking. Seizure duration dropped by 53%, and the number of seizures fell by 83%. The team found no serious side effects or reasons to stop the treatment early. Safety looked promising for this specific approach.
However, this is preliminary evidence from a first-in-patient study. We do not yet know how it works over months or years. More research is needed to confirm if these early gains last. Still, this supports the idea that this stimulation could be a candidate therapy for those who have not found relief from other treatments.